Trial Profile
A study evaluating effect of treatment of ledipasvir-sofosbuvir for hepatitis C virus infection on reactivation of hepatitis B virus in a community based setting.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jul 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis B; Hepatitis C
- Focus Therapeutic Use
- 08 Jul 2017 New trial record